ArticleCureus2026
Cesarean Myomectomy: A Retrospective Observational Study at a Tertiary Care Center in Bihar, India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Fibroids during pregnancy are frequently encountered in our routine obstetric practice. Whether cesarean myomectomy is a safe and practical treatment for women with uterine myomas or if it is completely contraindicated is a topic of much discussion. Due to the apprehension of increased blood loss, there remains a dilemma in obstetricians' decisions on whether to do a cesarean myomectomy or not. Our article may help obstetricians to make an informed decision. Method We did a single-center, uncontrolled, retrospective observational study on 25 cases who were enrolled over two years. Data were analyzed in terms of intraoperative blood loss, need for blood transfusion, operative time, hospital stay, and postoperative morbidity. Results The mean age of patients in our study was 29.1 years, and the mean gestational age at delivery in our study was 37.5 weeks. In our study, the size of uterine fibroids ranged between 4 and 16 cm. The mean operative time was 68.12 minutes. The mean drop in hemoglobin between pre- and post-op was 1.1 g/dL. There was a history of blood transfusion in seven out of 25 cases. There was no significant postoperative morbidity in all the cases, except for one, and the mean hospital stay was five days. Neonatal outcome was good in 22 cases with three neonatal intensive care unit (NICU) admissions. Conclusion This study concluded that myomectomy is feasible with acceptable short-term outcomes with good technique in expert hands in a tertiary care center. This has the advantages of avoiding a second surgery and cost when cases are selected appropriately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.